NEWS
Aug 12, 2026

SSRP Institute Welcomes IntellxxDNA as New Trusted Partner

PARTNER ANNOUNCEMENT

WILLOUGHBY, Ohio, [August 12, 2026] — The SSRP Institute welcomes IntellxxDNA to its Trusted Partner Network following a nomination and internal vetting process, aligning with SSRP's mission to advance science-first, education-driven clinical collaboration.

IntellxxDNA provides clinicians with a structured genomic decision support platform that translates complex genetic data into clinically actionable insights. Using curated SNP interaction analysis supported by peer-reviewed literature, their reports help identify additive risk patterns across neurological, metabolic, immune, and cardiometabolic pathways, while offering evidence-based intervention considerations related to lifestyle, nutrition, supplements, and medications.

“What excites me about IntellxxDNA and what they do is that it gives us a glimpse into each patient’s unique genetic makeup; a roadmap that helps us navigate their treatment and personalize the way we approach their care. What works for one patient might not work for another. Genomics is about connecting those dots and fully utilizing the available information to make each treatment fully individualized, leaving less to guesswork and more to what makes that patient uniquely them.” says Sanja Ryan, FNP and nominating SSRP Member. 

For SSRP Members, IntellxxDNA offers a practical way to integrate genomics into everyday clinical strategy without the time burden or complexity typically associated with genetic interpretation. Their clinician-only reporting system organizes relevant findings into clear, referenced summaries and highlights gene-to-gene and gene-environment interactions that influence common chronic conditions such as cognitive decline, mood disorders, cardiometabolic dysfunction, and neurodevelopmental challenges. Providers can access IntellxxDNA through a licensed clinician account, which includes training resources, sampler reports, and case-based education designed to support confident implementation in practice.

Carol Bilich, CEO of IntellxxDNA, said: "What is right for one patient, whether a peptide, supplement, medication, dietary strategy, or lifestyle change, may not be right for another. Genomics can help reveal why. SSRP and IntellxxDNA share a commitment to translating science into thoughtful, personalized clinical care and helping clinicians understand more of the individual patient. We are proud to be named a Trusted Partner and to support clinicians in making more informed, precise decisions."

Through these partnerships, the SSRP aims to support Members by connecting them with vetted resources that complement training, protocol development, and implementation in practice.

For more information and to view the IntellxxDNA Partner Page, visit:  SSRP IntellxxDNA Partner Page


About the SSRP Institute

The SSRP Institute is an education-focused organization dedicated to advancing cellular medicine through evidence-based training, professional collaboration, and clinically relevant research. SSRP supports providers worldwide through certifications, events, and ongoing educational programming designed to improve patient outcomes and elevate the standard of care.

The SSRP Trusted Partner Network is invitation-only and based on real-world clinical relevance, thoughtful nomination, and alignment with SSRP’s educational principles. Partners are integrated through a structured process designed to foster collaboration, support clinician education, and strengthen the implementation of cellular medicine practices.

RELATED RESOURCES

Continue exploring related topics.

VIEW ALL
Peptide Therapy Certification 2026
The SSRP Peptide Therapy Certification course gives clinicians, researchers, and other healthcare providers a working method for applying Cellular Medicine principles to patient care through clinical peptide therapy. Across 19 faculty-led lessons, Dr. William Seeds and SSRP faculty, including Siobhan...
19 Lessons
15 hrs 43 min
View Course
VIDEO
Cellular Medicine Mondays
Sep 21, 2026
Ep. 106 - Peptide Support After Transplant: What to Consider First
Preview only
Dissecting Protocols – Episode 106

Peptide Support After Transplant: What to Consider First

Dr. Seeds explores how to protect graft integrity and identify the right cellular targets before considering peptide support in a patient six years post liver transplant.

Preview Only — Become a member for full access
SSRP Institute Sep 14, 2026
In Case You Missed it: FDA Approves Mounjaro (tirzepatide) for CVD
HEADLINE SCIENCE [Sept 14, 2026] – On August 28, 2026, the FDA expanded the indication for Mounjaro (tirzepatide), approving the dual GIP/GLP-1 receptor agonist to reduce the risk of major adverse cardiovascular events—including cardiovascular death, nonfatal myocardial infarction, and nonfatal stroke—in adults with type 2 diabetes at high cardiovascular risk. The decision makes tirzepatide the […]
READ NEWS
EVENT
Certification
September 10 - 11, 2027
Peptide Therapy Certification 2027
Four Seasons Resort Orlando at Walt Disney World, FL
COMING SOON
Certification
Peptide Therapy Certification 2027
COMING SOON
EVENT
World Congress
June 17 - 19, 2027
Peptide World Congress 2027
Arizona Biltmore, Phoenix, AZ
COMING SOON
World Congress
Peptide World Congress 2027
COMING SOON
EVENT
Mastermind
February 15 - 19, 2027
Fellowship Mastermind Summit 2027
Gansevoort Meatpacking NYC, New York, NY
COMING SOON
Mastermind
Fellowship Mastermind Summit 2027
COMING SOON
EVENT
Grand Rounds
December 4 - 5, 2026
Grand Rounds
Four Seasons Resort and Residences Vail
COMING SOON
Grand Rounds
Grand Rounds
COMING SOON
VIDEO
Cellular Medicine Mondays
Sep 14, 2026
Ep. 105 - Dr. Seeds’ Office Hours
Preview only
VIDEO
Cellular Medicine Mondays
Sep 7, 2026
Ep. 104 - Phenotyping is Essential to Cellular Medicine
Preview only
Rabbit Holes – Episode 104

Phenotyping is Essential to Cellular Medicine

In this episode of Rabbit Holes, Dr. Seeds breaks down why phenotyping is essential to Cellular Medicine. Understanding the individual patient allows for more precise, personalized care instead of guessing or relying on random peptide protocols.

Preview Only — Become a member for full access
VIDEO
Cellular Medicine Mondays
Aug 31, 2026
Ep. 103 - Liposomal Peptides
Preview only
Dissecting Protocols – Episode 103

Liposomal Peptides

Dr. Seeds takes a closer look at liposomal peptides, including Epitalon, BPC-157, TB4, KPV, and GHK-Cu, and examines the claims around sourcing, stability, absorption, bioavailability, injection fatigue, and whether these formulations can truly compare to injectable peptides.

Preview Only — Become a member for full access

Subscribe to the SSRP Community Digest

Get the latest research and developments in the field of Cellular Medicine straight to your inbox every month.

This field is for validation purposes and should be left unchanged.